Brachytherapy Kit: Advantage-Strand® and Advantage-Load® with Advantage I-125®
Brachytherapy Kit: Advantage-Strand® and Advantage-Load® with Advantage I-125® radioactive seeds.
KXK
Source, Brachytherapy, Radionuclide
Advantage-Strand® and Advantage-Load® with Advantage I-125®
Advantage I-125® radioactive seeds with a molded form that is shielded on one si
Advantage I-125® radioactive seeds with a molded form that is shielded on one side and contains grooved positions for manual brachytherapy sources on the other side and is used for the temporary topical application of brachytherapy sources to the surface of the eye.
Advantage Pd-103 radioactive seeds with a molded form that is shielded on one si
Advantage Pd-103 radioactive seeds with a molded form that is shielded on one side containing grooved positions for manual brachytherapy sources on the other side used for the temporary topical application of brachytherapy sources to the surface of the eye; sterile.
The SIRIUS MRI Marker NS is a component device indicated as an accessory for use
The SIRIUS MRI Marker NS is a component device indicated as an accessory for use in conjunction with brachytherapy seed carrier sleeves and radionuclide brachytherapy sources containing one of the following isotopes: Iodine 125 (125I), Palladium 103 (103Pd) or Cesium 131 (131Cs). It is indicated for permanent interstitial implantation in the prostate of patients with confirmed prostatic malignancy.
The SIRIUS MRI Marker is a component device indicated as an accessory for use in
The SIRIUS MRI Marker is a component device indicated as an accessory for use in conjunction with brachytherapy seed carriersleeves and radionuclide brachytherapy sources containing one of the following isotopes: Iodine 125 (125I), Palladium 103(103Pd) or Cesium 131 (131Cs). It is indicated for permanent interstitial implantation in the prostate of patients with confirmedprostatic malignancy.
The SIRIUS MRI Marker is a component device indicated as an accessory for use in
The SIRIUS MRI Marker is a component device indicated as an accessory for use in conjunction with brachytherapy seed carrier sleeves and radionuclide brachytherapy sources containing one of the following isotopes: Iodine 125 (125I), Palladium 103 (103Pd) or Cesium 131 (131Cs). It is indicated for permanent interstitial implantation in the prostate of patients with confirmed prostatic malignancy.